{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06466434",
            "orgStudyIdInfo": {
                "id": "2024-0387"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2024-05150",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma",
            "officialTitle": "Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "prebiotic-food-enriched-diet-prefed-to-enhance-the-microbiome-and-response-to-first-line-immunotherapy-in-unresectable-melanoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-14",
            "studyFirstSubmitQcDate": "2024-06-14",
            "studyFirstPostDateStruct": {
                "date": "2024-06-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "To learn about the possible effects of a prebiotic food-enriched diet (PreFED) targeting the gut microbiome in participants with melanoma who are starting immune checkpoint blockade (ICB) therapy.",
            "detailedDescription": "Primary Objectives\n\n\u2022 Evaluate the effect of dietary intervention on the abundance of Faecalibacterium in stool samples from baseline to 12 weeks\n\nSecondary Objectives\n\n* Determine the best overall response rate (BORR) to PreFED + ICB regimens and landmark ORR at 12 weeks (intervention) and 24 weeks (maintenance)\n* Determine progression-free survival (PFS) and overall survival (OS) with PreFED + ICB regimens\n* Compliance and adherence to the dietary intervention at 12 weeks and maintenance at 24 weeks\n* Determine the safety (diet-related AEs) and tolerability (GSRS-IBS) of the dietary intervention at 12 weeks and maintenance at 24 weeks\n* Assess the rate of immune related adverse events in patients on ICB regimens receiving dietary intervention at 12 weeks and maintenance at 24 weeks\n* Assess the effects of dietary intervention on systemic and tumor immunity\n* Assess the effect of dietary intervention on overall gut microbiome composition and networks at 12 weeks and maintenance at 24 weeks\n* Assess the effects of dietary intervention on gut metabolic output and systemic metabolism at 12 weeks and maintenance at 24 weeks\n* Assess the effects of dietary interventions on quality of life and other patient reported outcomes (PROs) at 12 weeks and maintenance at 24 weeks"
        },
        "conditionsModule": {
            "conditions": [
                "Unresectable Melanoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 75,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Prebiotic food-enriched diet (PreFED)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive prebiotic food-enriched snacks and supportive nutritional counseling to increase prebiotic foods in the diet.",
                    "interventionNames": [
                        "Other: Prebiotic Food-Enriched Diet"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Prebiotic Food-Enriched Diet",
                    "description": "Given by PO",
                    "armGroupLabels": [
                        "Prebiotic food-enriched diet (PreFED)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Evaluate the effect of dietary intervention on the abundance of Faecalibacterium in stool samples from baseline.",
                    "timeFrame": "Up to 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226518 years old\n* Able to self-complete study assessments monitoring diet and gastrointestinal symptom burden\n* Body mass index (BMI) 18.5-45 kg/m2\n* ECOG performance status of 0 or 1\n* Histologically confirmed stage III/IV, unresectable cutaneous or mucosal melanoma. Asymptomatic brain metastases are allowed.\n* Planned initiation of 1st line standard-of-care approved immune checkpoint blockade (anti-PD1 +/- anti-CTLA4 or anti-LAG3 inhibitors) in the metastatic setting (prior ICB in adjuvant setting is allowed if last exposure \u2265 6 months prior). Prior targeted therapy is also allowed.\n* Returning to MD Anderson for restaging and follow-up (ICB treatment may occur locally)\n* WOCP must have negative UPT within 1 week of beginning dietary intervention.\n* Self-reported willingness to eat the provided foods (with some tailoring to their food preferences)\n* Self-reported willingness to comply with scheduled visits, undergo venipuncture, provide stool samples.\n\nExclusion Criteria:\n\n* Uveal melanoma previous ICB treatment in the metastatic setting\n* History of inflammatory bowel disease, total colectomy, or bariatric surgery.\n* Currently taking steroids \\> Prednisone 10 mg/day or equivalent\n* Medical contraindications to the Intervention Diet as determined by the treating physician.\n* Self-reported major dietary restrictions, including but not limited to relevant food allergies, celiac disease, or diets such as vegan, ketogenic, extended fasting.\n* Insulin-dependent diabetes or condition requiring bile acid sequestrants\n* Unable or unwilling to undergo study procedures.\n* IV antibiotic use in the past month or oral antibiotic use in past 2 weeks.\n* Regularly taking supplements containing prebiotics, fiber and/or probiotics, and unable/unwilling to discontinue for the purpose of the study.\n* Current smoker or heavy drinker (defined as \\>14 drinks per week) or current illicit drug use.\n* Currently pregnant, planning to become pregnant, or lactating.\n* Concurrent malignancy requiring systemic therapy other than hormonal therapy.\n* Cognitively impaired adults",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jennifer McQuade, MD",
                    "role": "CONTACT",
                    "phone": "(713) 745-9947",
                    "email": "jmcquade@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jennifer McQuade, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "MD Anderson Cancer Center",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "MD Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008545",
                    "term": "Melanoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000018326",
                    "term": "Nevi and Melanomas"
                },
                {
                    "id": "D000012878",
                    "term": "Skin Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "asFound": "Melanoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12448",
                    "name": "Nevus, Pigmented",
                    "relevance": "LOW"
                },
                {
                    "id": "M12446",
                    "name": "Nevus",
                    "relevance": "LOW"
                },
                {
                    "id": "M20470",
                    "name": "Nevi and Melanomas",
                    "relevance": "LOW"
                },
                {
                    "id": "M15681",
                    "name": "Skin Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}